EmaxHealth Health News
Home » General Health » Drug Clinical Trials

Test Results Of Syrup Medicine Suspected To Have Contained Isopropyl Alcohol

Ads by Google

All About:
  • Drug Clinical Trials

By Armen Hareyan on April 25, 2007 - 2:09am for eMaxHealth

Further investigation by the Department of Health into the suspected case of syrup medicine containing isopropyl alcohol revealed that seven of the 17 bottles of syrup medicine claimed or labeled as "terbutaline" and were seized from the clinic of a private medical practitioner in Tuen Mun contained isopropyl alcohol.

Tests by the Government Laboratory showed that the concentration of isopropyl alcohol ranged from 68 percent to 71 percent.

The 17 bottles of syrup medicine comprised two original stock bottles (3.6 liters per bottle), one medium-sized bottle (500-ml in volume) and 14 small bottles (30-45 ml in volume). Isopropyl alcohol was found in the medium-sized bottle and six of the small bottles.

A 3.6-liter bottle of isopropyl alcohol with a concentration of 75 percent was also found in the clinic.

Meanwhile, DH obtained three bottles of the syrup medicine concerned from three of the six patients (including the three-year-old girl who sought medical consultation at the Accident and Emergency Department of Tuen Mun Hospital on April 20). The drug was reported to have been dispensed by the private doctor concerned.

Tests results of these three bottles of syrup medicine indicated that two of them did not contain isopropyl alcohol. The one dispensed to the three-year-old girl was found to have contained isopropyl alcohol and the concentration of which is about 69 percent.

The hotline 2125 1133 set up by DH has so far received a total of 19 calls. None of them reported to have sought consultation from the doctor concerned.

Source: 
Hong Kong Department Of Health

eMaxHealth welcomes yourcomments and feedback on this story without registration, but keep the comments meaningful please. Links are not accepted.

  • Add new comment

Similar Stories

  • Medical Research in 2012 a Risk to the United States
  • Dexpramipexole promising in phase II trial for Lou Gehrig's disease
  • Lilly drug evacetrapib dramatically raises HDL cholesterol in trial
  • Genzyme’s MS Drug Lemtrada Gets Positive Results in Clinical Trial
  • Vorapaxar TRACER study halted after safety review

 Dr. Oz Promotes Magnet Cure
 Skin Care Secrets in Your Kitchen
 3 Gadgets to Make You Look 10 Years Younger
 Catalase is the Culprit for Gray Hair
 Vibration Therapy Helps Chronic Pain
 What If Antidepressants Don't Work
 When Obesity is OK for Some

Health Categories

 EMAXHEALTH HOME
 AFFORDABLE HEALTH INSURANCE
 DIET & WEIGHT LOSS
 FITNESS & EXERCISE
 MEN'S HEALTH
 WOMEN'S HEALTH
 BEAUTY
 ALTERNATIVE MEDICINE
 CANCER TREATMENT
 AGING
 DISEASE and CONDITION
 MENTAL HEALTH
 GENERAL HEALTH
 PERSONAL HEALTH
 GOURMET FOOD & HEALTH
 HEALING & SPIRITUALITY
 MONEY AND HEALTH
 Comment Moderation
  • Health RSS Feeds
  • Privacy Policy
  • Disclaimer
  • About Us
  • Editorial Review Process
  • Advertise
  • Contact
  • Contributors
Copyright eMaxhealth.com 2005-2012. All rights reserved.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.